Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis

Journal of Clinical Epidemiology

Volumn 61, Issue 1, 2008, Pages 64-75

  Wetterslev, Jørn ^a   Thorlund, Kristian ^a   Brok, Jesper ^a   Gluud, Christian ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cumulative meta analysis; Heterogeneity; Information size; Meta analysis; Sample size; Trial sequential monitoring boundaries; Type I error; Type II error

Indexed keywords

ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; IMMUNOGLOBULIN; NITRIC OXIDE; PLACEBO; SURFACTANT;

ANALYTICAL ERROR; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; CUMULATIVE META ANALYSIS; DIET SUPPLEMENTATION; ENTEROCOLITIS; HUMAN; META ANALYSIS; NEWBORN CARE; NEWBORN DISEASE; NEWBORN INFECTION; NEWBORN MORBIDITY; NEWBORN MORTALITY; OUTCOMES RESEARCH; PNEUMOTHORAX; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY FAILURE; SAMPLE SIZE; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

DATA INTERPRETATION, STATISTICAL; EVIDENCE-BASED MEDICINE; HUMANS; INFANT CARE; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; META-ANALYSIS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SAMPLE SIZE;

EID: 37049035730     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2007.03.013     Document Type: Article

References (46)

1. Schulz K.F., Charmers I., Hayes R.J., and Altman D.G. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273 (1995) 408-412
2. Moher D., Pham B., Jones A., Cook D.J., Jadad A.R., Moher M., et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 352 (1998) 609-613
3. Kjaergard L.L., Villumsen J., and Gluud C. Reported methodological quality and discrepancies between large and small randomized trials in meta-analyses. Ann Int Med 135 (2001) 982-989
4. Als-Nielsen B, Gluud LL, Gluud C. Methodological quality and treatment effects in randomised trials-a review of six empirical studies [abstract]. 12th International Cochrane Colloquium, Ottawa, 2004:88-89.
5. Chan A.W., Hrobjartsson A., Haahr M.T., Gotzsche P.C., and Altman D.G. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 291 (2004) 2457-2465
6. Chan A.W., and Altman D.G. Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors. BMJ 330 (2005) 753
7. Dickersin K., and Rennie D. Registering clinical trials. JAMA 290 (2003) 516-523
8. Montori V.M., Devereaux P.J., Adhikari N.K., Burns K.E., Eggert C.H., Briel M., et al. Randomized trials stopped early for benefit: a systematic review. JAMA 294 (2005) 2203-2209
9. Als-Nielsen B, Chen W, Gluud LL, Siersma V, Hilden J, Gluud C. Are trial size and reported methodological quality associated with treatment effects? Observational study of 523 randomised trials [abstract]. 12th International Cochrane Colloquium, Ottawa, 2004:102-103.
10. Berkey C.S., Mosteller F., Lau J., and Antman E.M. Uncertainty of the time of first significance in random effects cumulative meta-analysis. Control Clin Trials 17 (1996) 357-371
11. Trikalinos T.A., Churchill R., Ferri M., Leucht S., Tuunainen A., Wahlbeck K., et al., EU-PSI project. Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time. J Clin Epidemiol 57 (2004) 1124-1130
12. Ioannidis J.P.A. Contradicted and initially stronger effects in highly cited clinical research. JAMA 294 (2005) 218-228
13. Armitage P. Sequential analysis in therapeutic trials. Annu Rev Med 20 (1969) 425-430
14. Pocock S.J. Group sequential methods in the design and analysis of clinical trials. Biometrika 64 (1977) 191-199
15. Lan K.K.G., and DeMets D.L. Discrete sequential boundaries for clinical trials. Biometrika 70 (1983) 659-663
16. Pogue J., and Yusuf S. Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. Control Clin Trials 18 (1997) 580-593
17. Pogue J., and Yusuf S. Overcoming the limitations of current meta-analysis of randomised controlled trials. Lancet 351 (1998) 47-52
18. Higgins J.P., and Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 21 (2002) 1539-1558
19. Altman D.G., and Deeks J.J. Meta-analysis, Simpson's paradox, and the number needed to treat. BMC Med Res Methodol 2 (2002) 3
20. In: Egger M., Smith G.D., and Altman D.G. (Eds). Systematic reviews in health care: meta-analysis in context. 2nd edition (2001), BMJ Publishing Group
21. Egger M., Smith D.G., and Sterne J.A.C. Meta-analysis. Is moving the goal post the answer?. Lancet 351 (1998) 1517
22. Soll R.F. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 4 (1997) CD000511 10.1002/14651858
23. Finer N.N., and Barrington K.J. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev 4 (2001) CD000399 10.1002/14651858
24. Barrington K.J. Umbilical artery catheters in the newborn: effects of position of the catheter tip. Cochrane Database Syst Rev 2 (2000) CD000508 10.1002/14651858
25. Ohlsson A., and Lacy J.B. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database Syst Rev 1 (2004) CD001239 10.1002/14651858 pub2
26. Bury R.G., and Tudehope D. Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants. Cochrane Database Syst Rev 2 (2000) CD000405 10.1002/14651858
27. Brion L.P., Bell E.F., and Raghuveer T.S. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 4 (2003) CD003665 10.1002/14651858
28. Brok J., Greisen G., Jacobsen T., Gluud L.L., and Gluud C. Agreement between Cochrane Neonatal Group reviews and clinical guidelines for newborns at a Copenhagen University Hospital-a cross-sectional study. Acta Paediatr 96 (2007) 39-43
29. Reboussin D.M., DeMets D.L., Kim K.M., and Lan K.K. Computations for group sequential boundaries using the Lan-DeMets spending function method. Control Clin Trials 21 (2000) 190-207
30. Kelly P.J., Sooriyarachchi M.R., Stallard N., and Todd S. A practical comparison of group sequential and adaptive designs. J Biopharm Stat 15 (2005) 719-738
31. Bjelakovic G., Nikolova D., Simonetti R.G., and Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 364 (2004) 1219-1228
32. Bjelakovic G., Nikolova D., Simonetti R.G., Gluud L.L., and Gluud C. Antioxidant supplements. mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297 (2007) 842-857
33. Poston L., Briley A.L., Seed P.T., Kelly F.J., Shennan A.H., and Vitamins in Pre-eclampsia (VIP) Trial Consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 367 (2006) 1145-1154
34. Fedorov V., and Jones B. The design of multicentre trials. Stat Methods Med Res 14 (2005) 205-248
35. Flather M.D., Farkouh M.E., Pogue J.M., and Yusuf S. Strengths and limitations of meta-analysis: larger studies may be more reliable. Control Clin Trials 18 (1997) 568-579
36. Goodman S.N., and Berlin J.A. The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results. Ann Int Med 121 (1994) 200-206
37. Chow S.-C., Shao J., and Wang H. Chapter 8.8.1. In: Chow S.-C. (Ed). Sample size calculation in clinical research (2003), CRC, Taylor & Francis Group 204-206
38. Ioannidis J.P. Why most published research findings are false. PLoS Med 2 (2005) e124
39. Devereaux P.J., Beattie W.S., Choi P.T., Badner N.H., Guyatt G.H., Villar J.C., et al. How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ 331 (2005) 313-321
40. Juul A.B., Wetterslev J., Gluud C., Kofoed-nevoldsen A., Jensen G., Callesen T., et al. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ 332 7556 (2006) 1482
41. Brok J., Thorlund K., Wetterslev J., and Gluud C. Trial sequential analyses of positive Cochrane Neonatal meta-analyses considering adequacy of allocation concealment. Clin Trials 3 (2006) 241
42. Woods K.L., and Abrams K. The importance of effect mechanism in the design and interpretation of clinical trials: the role of magnesium in acute myocardial infarction. Prog Cardiovasc Dis 44 (2002) 267-274
43. Ioannidis J.P., Contopoulos-Ioannidis D.G., and Lau J. Recursive cumulative meta- analysis: a diagnostic for the evolution of total randomized evidence from group and individual patient data. J Clin Epidemiol 52 (1999) 281-291
44. Diamond G.A., and Kaul S. Prior convictions: Bayesian approaches to the analysis and interpretation of clinical megatrials. J Am Coll Cardiol 43 (2004) 1929-1939
45. Higgins J.P., and Spiegelhalter D.J. Being skeptical about meta-analyses: a Bayesian perspective on magnesium trials in myocardial infarction. Int J Epidemiol 31 (2002) 96-104
46. In: Deeks J.J., Higgins J.P.T., Altman D.G., and on behalf of the Cochrane Statistical Methods Group (Eds). Analysing and presenting results. Cochrane handbook for systematic reviews of interventions 4.2.6 (2006) 142-151. http://www.cochrane.org/resources/handbook/hbook Section 4